Assessment of the Accuracy, Usability and Acceptability of a Rapid Test for the Simultaneous Diagnosis of Syphilis and HIV Infection in a Real-Life Scenario in the Amazon Region, Brazil
- PMID: 36832298
- PMCID: PMC9955085
- DOI: 10.3390/diagnostics13040810
Assessment of the Accuracy, Usability and Acceptability of a Rapid Test for the Simultaneous Diagnosis of Syphilis and HIV Infection in a Real-Life Scenario in the Amazon Region, Brazil
Abstract
We field-assessed the accuracy, acceptability, and feasibility of the SD BIOLINE HIV/Syphilis Duo rapid diagnostic test in three groups: pregnant women, female sex workers (FSW), and men who have sex with men (MSM). Venous blood samples collected in the field were compared with the respective gold standard methods: SD BIOLINE HIV/Syphilis Duo Treponemal Test versus FTA-abs (Wama brand) treponemal laboratory test for syphilis, and SD BIOLINE HIV/Syphilis Duo Test versus the fourth generation Genscreen Ultra HIV Ag-Ag (Bio-Rad brand) laboratory test for HIV. From a total of 529 participants, 397 (75.1%) were pregnant women, 76 (14.3%) FSW and 56 (10.6%) MSM. Sensitivity and specificity parameters of HIV were 100.0% (95% CI: 82.35-100.0%) and 100.0% (95% CI: 99.28-100.0%), respectively. Sensitivity and specificity parameters found for TP antibody detection were 95.00% (95% CI: 87.69-98.62%) and 100.0% (95% CI: 98.18-100.0%), respectively. The SD BIOLINE HIV/Syphilis Duo Test showed high acceptability among participants (85.87%) and health professionals (85.51%), as well as easy usability by professionals (91.06%). The usability of the SD BIOLINE HIV/Syphilis Duo Test kit would not be a barrier to accessing rapid testing, if the product were incorporated into the list of health service supplies.
Keywords: Amazon; HIV; SD bioline duo assay; Syphilis; diagnosis; duo test; kappa coefficient; screening; sensitivity; specificity.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Ministério da Saúde . Protocolo Clínico e Diretrizes Terapêuticas para Prevenção da Transmissão Vertical de HIV, Sífilis e Hepatites Virais. Ministério da Saúde; Brasília, Brazil: 2020.
-
- Ministério da Saúde . Boletim Epidemiológico do HIV/Aids. Ministério da Saúde; Brasília, Brazil: 2021.
-
- Ministério da Saúde . Boletim Epidemiológico de Sífilis. Ministério da Saúde; Brasília, Brazil: 2021.
-
- World Health Organization WHO Information Note on the Use of Dual HIV/Syphilis Rapid Diagnostic Tests (RDT) 2017. [(accessed on 10 November 2022)]. Available online: https://apps.who.int/iris/bitstream/handle/10665/252849/WHO-RHR-17.01-en....
Grants and funding
LinkOut - more resources
Full Text Sources
